SERODIA -Chagas is an in-vitro diagnostic test kit for the detection of antibodies to Trypanosoma cruzi in human serum/plasma. This test is based on Fujirebio's particle-agglutination assay using gel
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease).
Inquire
Silicone ICD lead
Medicine Products:(Date:7/18/2008)...istance to chemotherapy drugs, sometimes abruptly,...ing well to reduce tumors or hold them in check? ...lt when this occurs is all too familiar: patients ...ecome resistant. , A team of researchers at Cold...stand the genetic underpinnings of cancer therapy ...
(Date:7/18/2008)...swire/ -- Baxa Corporation, a,Denver-based manufac...,handling, packaging, and administering medicatio...site for health-system users of its software and,p...wn as eBUG for,electronic Baxa Users, Group, offer...ting a virtual ,community, for sharing pharmacy be...
(Date:7/18/2008)...wswire-USNewswire/ -- William S.,Harris, Ph.D., FA...ter,dated July 16:, Eating fish, especially oily...heart disease prevention. Fish is low in total and...ce minerals, and contains,long-chain omega-3 fatty...thy omega-3s include salmon, trout, albacore tuna,...
(Date:7/18/2008)...- Standing Tall announced today that,two-time Tony...e Peters has,joined its Board of Directors., "Sta...e in the area,that supports the most severely dis... "The children at Standing Tall gain mobility and ...rn to walk and talk as they also learn,reading, ma...
Breaking Medicine News(10 mins):Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:Baxa Corporation Launches New Electronic Users' Group Web Site 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 3Health News:Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children 2Better prostate cancer detection,
Prevention is better than cure
...h has shown that folate supplements, widely recomm...he chances of having twins. Professor Judith Lumle...e supplement trials and found women who took folat...ad a 50 per cent greater chance of having twins.//...
... in the retinal vein could not only make you loose...o blocked veins is so painful that the eye may hav...rsity California have devised a new instrument tha...bullets of blockage-dissolving drugs into a clogge...
Other Medicine News:Health News:Blocked viens block eye sight 2(Date:7/17/2008)...ire/ -- Impliant, Inc., a developer of,novel spine...y announced,that it conducted the first surgery in...f its TOPS(TM) System, a Total Posterior,Arthropla...or without facet,arthrosis and spondylolisthesis. ...urosurgeon at the Charlotte Neurosurgery and Spine...
(Date:7/17/2008)...pares favorably to data from other, technologies ...all/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR), a ...ment and,commercialization of cancer therapies, to...from two previously conducted Phase II trials of,N...ents. As an exploratory,endpoint of the single arm...
(Date:7/16/2008)...ire/ -- In the clinical phase I trial,AFF001, AFFi...ts planned,for this trial. The trial aims to inves...e Alzheimer,s vaccine (AFFITOPE AD01). In the tria...once and have so far tolerated,the vaccine extreme...ons,administered at monthly intervals and is due t...
(Date:7/16/2008)...RNewswire-FirstCall/ -- MAP,Pharmaceuticals, Inc. ...ts,from a Phase 2 study evaluating the safety, tol... asthmatics were published in the July,issue of Cu...icals is,developing MAP0004, an orally inhaled and...nt for migraine., The study results, which were f...
Breaking Medicine Technology:Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Neighborhoods play key role in how much people exercise study says 14519 1Neighborhoods play key role in how much people exercise study says 14519 2Neighborhoods play key role in how much people exercise study says 14519 3BUs School of Law Public Health to hold conference on the future of health law 14516 1BUs School of Law Public Health to hold conference on the future of health law 14516 2DRAXIS Responds to Trading 14512 1DRAXIS Responds to Trading 14512 2DRAXIS Responds to Trading 14512 3DRAXIS Responds to Trading 14512 4Frying Tumors Can Boost Lung Cancer Survival 14509 1Frying Tumors Can Boost Lung Cancer Survival 14509 2Frying Tumors Can Boost Lung Cancer Survival 14509 3...WIRE)--Apr 18, 2007 - Gemin,X today announced the ...tudy of its lead compound, GX15-070 (obatoclax), i...tudy was discussed in an,oral presentation at the ...cer Research (AACR). According to the study, GX15-...nst ALL blast cells,and also enhanced chemosensit...
...18, 2007 - Idera,Pharmaceuticals, Inc. (AMEX: IDP)... new potential applications in oncology of its nov...Annual Meeting of,the American Association for Can... April 14-18, 2007. The first presentation covered...y candidate,IMO-2055, in combination with the mul...
Other Medicine Technology:Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 2Gemin X Presents Positive Preclinical Data of GX15-070 in Infant,ALL at AACR Meeting 3Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 2Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 3Idera Pharmaceuticals Announces Presentations of Preclinical Data,on New Potential Oncology Applications of its TLR9 Agonists at AACR 4